Sunday, April 02, 2017 5:08:25 PM
blue eyed this is the truth.
you know I know it ..the longs know it.
a drug just doesn't stop insomnia in dementia patients without KNOCKING Them out, much less without making them drowsy.
something so incredible is going on here..
the good dr had to pull 15 month because the data is probably declaratory..
and out little fish is swimming in an ocean..
Our drug has already been tesed IN Vivo for MS..see WAYNE STATE University..
it worked ..it performed..NOW we KNOW it worked for Biogen..
i think Biogen is dirty..sorry..but i think they are the motivation behind Motley fool and probably Short Cabal of MM..I know that is not nice.
but most of these BP sold their souls a long time ago...
Praying for forgiveness for my many faults..but I am not
blaming the good Dr for not going to the store, buying a hanging rope,
throwing it around a high tree limb, tying his own knot, taking a break to dig a grave underneath the tree limb, then climbing the tree and jumping into his own grave..leaving only throwing dirt on top of him for Kleptocrats..I have lost before..I am with the good Dr...
If I lose again..won't be first..but I will tell you..
this is the ONLY TIME I have EVER felt like the guy at the top, was on MY SIDE..EVER.
you know I know it ..the longs know it.
a drug just doesn't stop insomnia in dementia patients without KNOCKING Them out, much less without making them drowsy.
something so incredible is going on here..
the good dr had to pull 15 month because the data is probably declaratory..
and out little fish is swimming in an ocean..
Our drug has already been tesed IN Vivo for MS..see WAYNE STATE University..
it worked ..it performed..NOW we KNOW it worked for Biogen..
i think Biogen is dirty..sorry..but i think they are the motivation behind Motley fool and probably Short Cabal of MM..I know that is not nice.
but most of these BP sold their souls a long time ago...
Praying for forgiveness for my many faults..but I am not
blaming the good Dr for not going to the store, buying a hanging rope,
throwing it around a high tree limb, tying his own knot, taking a break to dig a grave underneath the tree limb, then climbing the tree and jumping into his own grave..leaving only throwing dirt on top of him for Kleptocrats..I have lost before..I am with the good Dr...
If I lose again..won't be first..but I will tell you..
this is the ONLY TIME I have EVER felt like the guy at the top, was on MY SIDE..EVER.
Recent AVXL News
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
